Skip to content

Flex Intramedullary Rod Study

A Prospective, Post-market, Multi-center Comparative Study of the Efficacy of Flex Intramedullary(IM) Rod in Terms of Range of Motion (ROM) Improvement.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02543489
Enrollment
100
Registered
2015-09-07
Start date
2012-12-31
Completion date
2019-09-30
Last updated
2018-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthroplasty, Replacement, Knee, Osteoarthritis of the Knee

Brief summary

The purpose of this study is to compare the effect of post-operative ROM between Flex IM rod and Rigid IM rod, to collect bone morphology of Japanese lower extremity and to research the incidence of overhung with Flex IM rod.

Interventions

DEVICEFlex IM rod

Sponsors

Stryker Japan K.K.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patient has signed an Institutional Review Board (IRB) approved, study specific Informed Patient Consent Form. 2. Patient is a male or non-pregnant female age 20 years or older. 3. Patient is candidate for primary Total Knee Arthroplasty (TKA). 4. Patient whose preoperative range of motion (ROM) is over 110 degree. 5. Patient is willing and able to comply with postoperative scheduled clinical and radiographic evaluations and rehabilitation.

Exclusion criteria

1. Revision cases 2. Patients that use bone wedges or allograft due to bone loss. 3. Patient has a Body Mass Index (BMI) \>40. 4. Patient has an active or suspected latent infection in or about the affected knee joint at time of study device implantation. 5. Patient has a neuromuscular or neurosensory deficiency, which limits the ability to evaluate the safety and efficacy of the device. 6. Patient is diagnosed with a systemic disease (e.g. Lupus Erythematosus) or a metabolic disorder (e.g. Paget's Disease) leading to progressive bone deterioration. 7. Patient is immunologically suppressed or receiving steroids in excess of normal physiological requirements (e.g. \> 30 days). 8. Patient has failed unicondylar knee prosthesis. 9. Patient has a known sensitivity to device materials. 10. Patient who are inappropriate for participating in the study in the judgment of the investigator.

Design outcomes

Primary

MeasureTime frame
Maximum postoperative flexion angle48 weeks after surgery

Secondary

MeasureTime frame
Quality of life as assessed by36-Item Short-Form Health Survey (SF-36)questionnaire4 weeks , 24 weeks and 48 weeks after surgery
Japanese Knee Osteoarthritis Measure(JKOM)4 weeks , 24 weeks and 48 weeks after surgery
Knee Society Scale (KSS)4 weeks , 24 weeks and 48 weeks after surgery
Range of Motion (ROM)4 weeks , 24 weeks and 48 weeks after surgery

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026